| Frazier Life Sciences Public Fund, L.P. |
6.9% |
3,466,521 |
0 |
3,466,521 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P. |
0001863769 |
| FHMLSP, L.P. |
6.9% |
3,466,521 |
0 |
3,466,521 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P. |
0001879466 |
| FHMLSP, L.L.C. |
6.9% |
3,466,521 |
0 |
3,466,521 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLSP, L.L.C. |
0001879465 |
| Frazier Life Sciences X, L.P. |
2.3% |
1,160,700 |
0 |
1,160,700 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P., GP of Frazier Life Sciences X, L.P. |
0001790879 |
| FHMLS X, L.P. |
2.3% |
1,160,700 |
0 |
1,160,700 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P. |
0001790880 |
| FHMLS X, L.L.C. |
2.3% |
1,160,700 |
0 |
1,160,700 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS X, L.L.C. |
0001790811 |
| Frazier Life Sciences XI, L.P. |
0.8% |
394,847 |
0 |
394,847 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P., GP of Frazier Life Sciences XI, L.P. |
0001911592 |
| FHMLS XI, L.P. |
0.8% |
394,847 |
0 |
394,847 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P. |
0001911580 |
| FHMLS XI, L.L.C. |
0.8% |
394,847 |
0 |
394,847 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS XI, L.L.C. |
0001911623 |
| James N. Topper |
2.3% |
1,160,700 |
0 |
1,160,700 |
/s/ Steve R. Bailey |
By Steve R. Bailey, Attorney-in-Fact for James N. Topper, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017 |
0001341382 |
| Patrick J. Heron |
2.3% |
1,160,700 |
0 |
1,160,700 |
/s/ Steve R. Bailey |
By Steve R. Bailey, Attorney-in-Fact for Patrick J. Heron, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017 |
0001365617 |